期刊文献+

胃肠激素与肥胖关系的研究进展 被引量:10

Research on Correlations of Gastrointestinal Hormones and Calorigenic Nutrients for Obesity
原文传递
导出
摘要 胃肠激素(gastrointestinal hormone)是一类性质不同的具有激素或类激素功能的多肽,这些肽可将胃肠道的信号传递到食欲相关的脑区进行整合,然后沿神经纤维传递到神经末梢进行释放,从而调节细胞活动。胃肠激素在机体的能量稳态平衡中发挥重要调节作用。膳食中三种产能营养素的比例失调或不良的饮食行为会导致机体能量稳态调节失衡。目前研究认为,胃肠激素可能是有效治疗肥胖的新型潜在靶点,但其作用机制尚不清楚。因此,本文对ghrelin、胆囊收缩素(Cholecystokinin,CCK)和胰高血糖素样肽-1(Glucagon peptide-1,GLP-1)三种胃肠激素与肥胖的发生及发展之间关系进行综述。 Gastrointestinal hormone is a kind of peptides with hormones or hormone functions that could send signals to the appetite of gastrointestinal-related brain region for integration, and then pass along the nerve fibers to regulate the activities of the cells. Gastrointestinal hormones play the important role of energy homeostasis in the body. Researches have shown that the gastrointestinal hormone may be an effective and potential target for the treatment of obesity. However, it's unclear that the relationship of gut hormones, calorigenic nutrients and eating behaviors. Therefore, this paper aims to research the correlations of ghrelin, CCK and GLP-1 with obesity.
出处 《现代生物医学进展》 CAS 2015年第14期2786-2789,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81302417)
关键词 胃肠激素 肥胖 产能营养素 FMRI Gastrointestinal hormone Obesity Calorigenic nutrients
  • 相关文献

参考文献28

  • 1Farooqi IS, O'Rahilly S. Monogenic obesity in humans [J]. Annu Rev Med, 2005, 56(1): 443-458.
  • 2Halford JC. Pharmacotherapy for obesity [J]. Appetite, 2006, 46(I): 6-10.
  • 3James WP, Astrup A, Finer N, et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance [J]. Lancet, 2000, 356(9248): 2119-2125.
  • 4Van Gaal LF, Rissanen AM, Scheen A J, et al. Effects of the cannabinoid-I receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: l-year experience from the RIO-Europe study[J]. Lancet, 2005, 365(9468): 1389-1397.
  • 5Schwartz MW, Woods SC, Porte D, et al. Central nervous system control of food intake[J]. Nature, 2000, 404(6778): 661-671.
  • 6Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated pcptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans[J]. Endocrinology, 2000, 141 ( I 1 ): 4255-4261.
  • 7Cummings DE, Purnell JQ, Fvayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans[J]. Diabetes, 2001, 50(8): 1714-1719.
  • 8Tschop M, Weyer C, Tataranni PA, et al. Circulating ghrelin levels are decreased in human obesity[J]. Diabetes, 2001, 50(4): 707-709.
  • 9Schwartz G J, Neary NM, Small C J, et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial [J]. J Clin Endocrinol Metab, 2004, 89(6): 2832-2836.
  • 10Liddle RA, Goldfine ID, Rosen MS, et al. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction [J]. J Clin Invest, 1985, 75(4): 1144-1152.

同被引文献113

引证文献10

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部